Jefferson, GA, United States of America

Crystal Jackson

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Crystal Jackson: Pioneering Innovator in PD-L1 Binding Molecules

Introduction

Crystal Jackson, a distinguished inventor based in Jefferson, Georgia, has made significant contributions to the field of biomedical innovations. With three patents to her name, she has focused on developing groundbreaking therapies that have the potential to revolutionize cancer treatment.

Latest Patents

Among her latest patents is a notable invention titled "PD-L1-binding molecules comprising Shiga toxin A subunit scaffolds." This innovative work involves PD-L1 binding molecules that are either composed of or conjugated to a Shiga toxin A subunit-derived polypeptide. These molecules have multiple applications, including their capacity to selectively kill PD-L1 positive tumor cells and deliver therapeutic agents directly to these cells. Another patent titled "Neutralizing monoclonal antibodies to IL-25 and uses thereof" highlights her work on IL-25 binding molecules and their therapeutic potential, further establishing her as a leading figure in the field.

Career Highlights

Crystal has been associated with several prominent companies throughout her career, including Molecular Templates, Inc. and Abeome Corporation. Her work has continuously pushed the boundaries of what is possible in therapeutic development, emphasizing her commitment to innovative healthcare solutions.

Collaborations

Throughout her career, Crystal has collaborated with notable coworkers such as Richard Shimkets and Thomas Vincent. These collaborations have contributed to her success in research and innovation, facilitating the exchange of ideas and expertise that drive her projects forward.

Conclusion

Crystal Jackson exemplifies the spirit of innovation in the biopharmaceutical industry. Her impressive portfolio of patents and her collaborative efforts with industry professionals highlight her dedication to advancing medical science. As she continues her work in developing targeted therapies, Crystal remains a vital contributor to the fight against cancer and related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…